M

Malaysian Genomics Resource Centre Bhd
KLSE:MGRC

Watchlist Manager
Malaysian Genomics Resource Centre Bhd
KLSE:MGRC
Watchlist
Price: 0.17 MYR -10.53% Market Closed
Market Cap: 25.7m MYR

Malaysian Genomics Resource Centre Bhd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Malaysian Genomics Resource Centre Bhd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
M
Malaysian Genomics Resource Centre Bhd
KLSE:MGRC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Malaysian Genomics Resource Centre Bhd
Glance View

Malaysian Genomics Resource Centre Bhd. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2010-01-25. The company provides genome sequencing and analysis, and genetic screening services. The company offers end-to-end genomics services that comprise genome sequencing, genome analysis, and genetic screening. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. The company offers both de novo sequencing and resequencing as part of its WGS service. Its genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individual’s deoxyribonucleic acid (DNA). Dtect also screens for genetic markers related to adverse reactions towards drugs used in treating certain diseases. The company operates dialysis centers through MGRC Healthcare Sdn Bhd.

MGRC Intrinsic Value
Not Available
M

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett